small-cap

Two stocks that got hammered – Virtus Health Ltd and Newcrest Mining Ltd

Nov 13, 2016 | Team Kalkine
Two stocks that got hammered – Virtus Health Ltd and Newcrest Mining Ltd


 
Virtus Health Ltd


VRT Details

·       Director resignation hurt the stock sentiment: Virtus Health Ltd (ASX: VRT) stock continued to fall over 5.9% on November 11, 2016 as the director resigned from the group. Mr Dennis O’Neill reported his resignation as the Director of the Company, and this move disappointed the market. VRT stock has been under pressure this month which fell over 12.4% (as of November 10, 2016) owing to the softness in first quarter of FY17 wherein the group reported that the IVF cycle activity in Australia is being impacted by short term local economic influences and accordingly the first quarter has seen a decline in fresh cycle activity which lost 3.5% as compared to the prior corresponding period. Virtus fresh cycle activity in the quarter has fallen 5.9% on a like for like basis. This indicates loss of market share in Victoria on the back of rising competition and new entrants. On the other hand, Sims Clinic cycle in Ireland rose 5.8% from prior year comparative quarter. Moreover, the group’s Singapore activity is witnessing 30 cycles per month and the unaudited first quarter EBITDA for Singapore was positive for the operation after two years of losses.

·       Recommendation: We give a “Hold” recommendation on the stock at the current price of $6.10
 
Newcrest Mining Ltd


NCM Details

·       Higher levels: Newcrest Mining Ltd (ASX: NCM) stock fell over 7.3% on November 11, 2016 due to gold price movement. The group is enhancing their production from their current operations. The pre-feasibility study is expanding throughput to 32 million tonnes per year at Cadia. NCM forecasts 13 million tonnes per annum by the end of December 2016. On the other hand, the current volatility in gold prices may impact the stock in the coming period. Moreover, NCM generated over 85% of returns during this year to date (as of November 10, 2016), placing the stock at higher P/E.

·       Recommendation: We maintain an “Expensive” recommendation on the stock at the current price of $22.47



Disclaimer 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.




Past performance is not a reliable indicator of future performance.